Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 17 Uterine Cervical Neoplasms 9 Endometrial Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Fallopian Tube Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Uterine Neoplasms 3 Pancreatic Neoplasms 3 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Genital Neoplasms, Female 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Trophoblastic Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Laparoscopy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Pemetrexed × Gynecologic × Clear all

NCT03875144 2026-02-09

MESOTIP

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Suspended

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡